Canada markets close in 6 hours 29 minutes

EyePoint Pharmaceuticals Inc (PV3B.MU)

Munich - Munich Delayed Price. Currency in EUR
Add to watchlist
8.64+0.08 (+0.96%)
As of 08:00AM CEST. Market open.
Full screen
Previous Close8.56
Open8.64
Bid8.52 x N/A
Ask8.78 x N/A
Day's Range8.64 - 8.64
52 Week Range5.25 - 27.40
Volume22
Avg. Volume0
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateJul 31, 2024 - Aug 05, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    WATERTOWN, Mass., June 17, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an

  • GlobeNewswire

    EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

    WATERTOWN, Mass., June 05, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that Jay S. Duker, M.D., President and Chief Executive Officer of EyePoint Pharmaceuticals will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024 at 3:20 p.m. ET. A live webcast and subsequent archived

  • GuruFocus.com

    Insider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT)

    On June 3, 2024, David Guyer, a Director at EyePoint Pharmaceuticals Inc (NASDAQ:EYPT), executed a sale of 11,625 shares of the company.